Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Advances in Nutrition (Bethesda, Md.)
|
September 18, 2012
Chemopreventive properties of dietary rice bran: current status and future prospects
Angela J Henderson, Cadie A Ollila, Ajay Kumar, et al.
Rhode Island Medical Journal (2013)
|
February 27, 2023
Testicular Relapse of Primary Diffuse Large B-cell Lymphoma of the Central Nervous System - a Rare Occurrence
Thomas A Ollila, Thomas P Kishkovich, Adam J Olszewski, et al.
Rhode Island Medical Journal (2013)
|
October 2, 2020
Enforcing the "4T": An In-Line Calculator for HIT Antibody Ordering in the Electronic Medical Record
Adam S Zayac, Ross W Hilliard, Adam J Olszewski, et al.
Blood
|
September 3, 2020
Genomic subtypes may predict the risk of central nervous system recurrence in diffuse large B-cell lymphoma
Thomas A Ollila, Habibe Kurt, Jozal Waroich, et al.
Haematologica
|
November 27, 2025
Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphoma
Adam J Olszewski, Thomas A Ollila, Dai Chihara, et al.
Cancer
|
July 11, 2022
Seroconversion and outcomes after initial and booster COVID-19 vaccination in adults with hematologic malignancies
Thomas A Ollila, Rebecca H Masel, John L Reagan, et al.
Scientific Reports
|
May 17, 2024
Radiation-induced alteration of apatite on the surface of Mars: first in situ observations with SuperCam Raman onboard Perseverance
E Clavé, O Beyssac, S Bernard, et al.
Blood Advances
|
September 22, 2021
Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma
Adam J Olszewski, Anna D Chorzalska, Max Petersen, et al.
Blood Cancer Journal
|
June 21, 2025
Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma-Results from a multicenter cohort study
Frederique St-Pierre, Subodh Bhatta, Peter G Doukas, et al.
Blood
|
April 21, 2026
Mosunetuzumab plus polatuzumab vedotin in relapsed/refractory MCL after BTK inhibitor therapy: a phase 2 study
Lihua E Budde, Manali Kamdar, Sarit E Assouline, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Advances in Nutrition (Bethesda, Md.)
|
September 18, 2012
Chemopreventive properties of dietary rice bran: current status and future prospects
Angela J Henderson, Cadie A Ollila, Ajay Kumar, et al.
Rhode Island Medical Journal (2013)
|
February 27, 2023
Testicular Relapse of Primary Diffuse Large B-cell Lymphoma of the Central Nervous System - a Rare Occurrence
Thomas A Ollila, Thomas P Kishkovich, Adam J Olszewski, et al.
Rhode Island Medical Journal (2013)
|
October 2, 2020
Enforcing the "4T": An In-Line Calculator for HIT Antibody Ordering in the Electronic Medical Record
Adam S Zayac, Ross W Hilliard, Adam J Olszewski, et al.
Blood
|
September 3, 2020
Genomic subtypes may predict the risk of central nervous system recurrence in diffuse large B-cell lymphoma
Thomas A Ollila, Habibe Kurt, Jozal Waroich, et al.
Haematologica
|
November 27, 2025
Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphoma
Adam J Olszewski, Thomas A Ollila, Dai Chihara, et al.
Cancer
|
July 11, 2022
Seroconversion and outcomes after initial and booster COVID-19 vaccination in adults with hematologic malignancies
Thomas A Ollila, Rebecca H Masel, John L Reagan, et al.
Scientific Reports
|
May 17, 2024
Radiation-induced alteration of apatite on the surface of Mars: first in situ observations with SuperCam Raman onboard Perseverance
E Clavé, O Beyssac, S Bernard, et al.
Blood Advances
|
September 22, 2021
Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma
Adam J Olszewski, Anna D Chorzalska, Max Petersen, et al.
Blood Cancer Journal
|
June 21, 2025
Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma-Results from a multicenter cohort study
Frederique St-Pierre, Subodh Bhatta, Peter G Doukas, et al.
Blood
|
April 21, 2026
Mosunetuzumab plus polatuzumab vedotin in relapsed/refractory MCL after BTK inhibitor therapy: a phase 2 study
Lihua E Budde, Manali Kamdar, Sarit E Assouline, et al.
Page
of 5